LLI

During the CAPiTA trial, data was collected which gave a relevant picture of the impact of a pneumococcal vaccination in both the incidence and the course and treatment of Community Acquired Pneumonia (CAP). However, many doctors pointed out during the study that the collection of data on CAP in the second line is just the tip of the iceberg: the large majority of all patients with pneumonia are viewed and treated in a primary care setting.

Therapeutic areas

Total patients

40000

Total sites

1100

Status

Active

Data on the effect of pneumococcal vaccination on the incidence and treatment of pneumonia in general practice are a welcome addition to the CAPiTA trial and are interesting and relevant to both daily practice and the development of a policy in this area.

Starting in Autumn 2013, data was retrospectively collected on the incidence and treatment of lower respiratory tract infections (LRTI) amongst CAPiTA participants that have not been treated in the hospital, but at the GP office. Data from 40,000 CAPiTA participants was collected for further analysis.

The LLI study was based on data already available within the general practice, and focuses primarily on data collection regarding lower respiratory tract infections.